Safety and tolerability of oxaliplatin based pressurized intraperitoneal aerosol chemotherapy (PIPAC) for patients with peritoneal carcinomatosis: A phase I dose-finding study in Asian patients.

Raghav Sundar,Guo Wei Kim,Hon-Lyn Tan,Lingzhi Wang,Koy Min Chue,Chia Hui Tai,Siok Chin Teo,Clarisse Jia Min Jang,Corissa Yi Juan Chee,Bettina Lieske,Cheng Ean Chee,Asim Shabbir,Jimmy So,Wei Peng Yong

Safety and tolerability of oxaliplatin based pressurized intraperitoneal aerosol chemotherapy (PIPAC) for patients with peritoneal carcinomatosis: A phase I dose-finding study in Asian patients.

2020

Raghav Sundar
Guo Wei Kim
Hon-Lyn Tan
Lingzhi Wang
Koy Min Chue
Chia Hui Tai
Siok Chin Teo
Clarisse Jia Min Jang
Corissa Yi Juan Chee
Bettina Lieske
Cheng Ean Chee
Asim Shabbir
Jimmy So
Wei Peng Yong

360Background: PIPAC is a novel, laparoscopic intraperitoneal chemotherapy delivery technique which aims to improve on hyperthermic intraperitoneal chemotherapy (HIPEC), ameliorating drug distribut...

Keywords:

Gastroenterology
Oxaliplatin
Internal medicine
Medicine
peritoneal carcinomatosis
Chemotherapy
Tolerability
Pathology
Hyperthermic intraperitoneal chemotherapy
dose finding
intraperitoneal chemotherapy
Drug

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations